AZD8233 / Ionis, AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD8233 / AstraZeneca
NCT03593785: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.

Completed
1
73
US
AZD8233
AstraZeneca, Parexel
Hypercholesterolemia
12/20
12/20
NCT04155645: To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia

Completed
1
34
US
AZD8233 subcutaneous injection, Placebo
AstraZeneca, Parexel
Dyslipidemia
06/21
06/21
NCT05065463: To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.

Terminated
1
3
Europe
AZD8233
AstraZeneca, Parexel
End Stage Renal Disease
11/22
11/22

Download Options